Back to Blog

PCT National Phase in Belgium: How to Reach the Market in 2026

PCT national phase in Belgium via the European patent route

If a pending international application needs to cover Belgium, start with the fact that catches most applicants out: you cannot enter the PCT national phase in Belgium as a direct step. Belgium closed its national route for PCT applications, so the only way in is the European regional phase followed by validation of the granted European patent. The good news is that validation in Belgium is the cheapest kind in Europe, because since 2017 it needs no translation at all. Here is how the route works in 2026 and where the deadlines bite.

The PCT National Phase in Belgium, Honestly Explained

PCT national phase in Belgium decision at the patent office
Photo: Nairobi- ‘Grains of Culture’ mural in support of Ukraine photo by Peter Hess by zug55 (CC BY-SA 4.0)

A PCT application is not a patent. It is a placeholder that buys you time, usually 30 or 31 months from your earliest priority date, to decide where you actually want protection. When that window closes, the international application lapses everywhere you have not converted it into real national or regional rights.

In most countries you convert directly at the national office. The PCT national phase in Belgium does not work like that, because Belgium no longer offers a national route for PCT applications. The Belgian office is not available as a destination for an international application; if you try to treat it as one, there is nothing to enter.

The way in is Europe. You enter the European regional phase at the European Patent Office, prosecute to grant, and then validate the granted European patent in Belgium. The result is a Belgian patent enforceable before the Belgian courts, identical in strength to a nationally granted one.

Why There Is No Direct National Route

Belgium is one of the EPC states that closed its national route for PCT applications. For those countries the European Patent Office is the only competent designated or elected Office, as set out in the WIPO PCT Applicant’s Guide for Belgium. File a PCT application and want Belgium, and the EPO is the body that carries it forward; the Belgian Office for Intellectual Property does not act as a designated Office for international applications.

The reasoning is the same as in the neighbouring Netherlands. Belgium is a founding EPC member, and nearly every patent enforced there arrives as a validated European patent. Keeping a parallel national PCT route added administration for a path almost nobody used, so Belgium pointed applicants to the European system that already dominates its market.

  • A PCT application cannot enter a Belgian national phase directly.
  • The EPO is the only designated Office through which a PCT application reaches Belgium.
  • Protection is obtained by validating the granted European patent, not by a national filing.

If you have filed in a country such as Italy, which reopened a direct national route in 2020, do not assume Belgium follows suit. The designated-Office position differs country by country, and in Belgium it sends you to the EPO.

The 31-Month Euro-PCT Deadline and Why It Is Unforgiving

Calendar marking the 31-month PCT national phase in Belgium deadline
Photo: <div class=’fn’> Double-axe head</div> by Gwynedd Archaeological Trust, Nina Steele, 2008-03-25 11:28:14 (CC BY-SA 4.0)

Because the Belgian route runs through Europe, your deadline is the European regional phase deadline: 31 months from your earliest priority date. Enter the European phase at the EPO by that date and Belgium stays live within your European application. Miss it and the international application lapses as to Belgium along with the rest of Europe.

Nothing warns you when the PCT phase ends, which is why a blown entry is the most expensive mistake in cross-border filing. The EPO does offer further processing for a late regional-phase entry, but treating it as a backstop is a planning failure; it carries fees and should never be your plan A.

Diary the 31-month date as hard, and set a six-month reminder so the European attorney, amendments and budget are ready well before the deadline week. Our guide to the PCT international application explains how that clock is set from the earliest priority date.

Entering the European Regional Phase, Step by Step

European phase entry is a defined checklist. By the 31-month date you file the entry at the EPO, pay the filing and designation fees, pay claims fees for any claims beyond the fifteenth, and pay the search fee if a supplementary European search is due. If the application was not in English, French or German, a translation into one of those EPO languages is required at entry.

You confirm the documents on which the EPO should proceed and may amend the claims in response to the international search opinion. This is a good moment to tighten the claims so examination starts cleanly. From there it is ordinary EPO prosecution: examination, any Article 94 communications, and ultimately the decision to grant.

If you also need to understand national-first filing before the PCT begins, our guide to filing a patent in Belgium sets out that groundwork and how it connects to the international route.

Validating in Belgium: No Translation Required

Translation-free validation completing the PCT national phase in Belgium
Photo: Istanbul Turkish and Islamic Museum TuฤŸra of Selim II 1569 in 2006 09 0897 by Dosseman (CC BY-SA 4.0)

Here is where Belgium stands out. For European patents whose grant was published on or after 1 January 2017, Belgium requires no translation at all to take effect. A European patent granted in English, French or German has the same force as a Belgian patent without any further translation into a Belgian national language.

That reform, which paved the way for Belgium’s accession to the London Agreement, makes Belgian validation one of the simplest and cheapest in Europe. There is no specification to translate, no claims translation to commission, and far less that can go wrong. You keep the Belgian part of your European patent alive principally by paying renewals, not by clearing a translation hurdle.

Because the validation step is so light, the mechanics are the same as for any European grant; our walkthrough of validating a European patent in Belgium covers the detail. If your figures need cleaning up before grant, see our note on patent drawings in Belgium.

Renewals, Fees and Where Belgian Disputes Are Heard

After validation, annual renewal fees are due to the Belgian Office for Intellectual Property to keep the Belgian part of your European patent in force. Budget them across the life of the patent; a lapsed renewal ends protection just as surely as a missed filing deadline.

Belgium concentrates patent disputes in one specialist forum. National infringement and validity cases are heard by the Brussels Enterprise Court, which holds exclusive jurisdiction over Belgian patent matters, giving you a single expert bench rather than a scatter of regional courts. Belgium also hosts a local division of the Unified Patent Court in Brussels, so a classically validated European patent can be litigated nationally while a unitary or opted-in patent can run through the UPC.

  • Renewals: paid annually to the Belgian Office for Intellectual Property after validation.
  • National litigation: the Brussels Enterprise Court has exclusive Belgian patent jurisdiction.
  • UPC option: a local division sits in Brussels for unitary and non-opted-out European patents.

If Belgium is one market in a wider European plan, the local view matters; see how we support clients through our Belgium IP services hub.

Common Mistakes and How to Plan Around Them

The first mistake is assuming a direct Belgian national phase exists and only discovering at month 29 that it never did. By then there may be too little time to brief a European attorney properly. Build the European decision into your 24-month portfolio review rather than the final fortnight.

The second is over-worrying about Belgian paperwork. Validation here is genuinely light since the 2017 reform, so the real risk is not the translation, which no longer exists, but the 31-month European entry that gates everything before it.

The third is treating Belgium in isolation. The European route that reaches Belgium also reaches Germany, France, the Netherlands and the rest of the EPC from a single prosecution. Map the full European footprint at entry, then validate in each country at the end, and Belgium becomes one cheap step rather than a separate project.

Reaching Belgium From a PCT Application

The 31-month European entry is the deadline that decides whether Belgium stays on the table. PerspireIP helps applicants map the European route, prepare clean claims, and keep every deadline docketed through to validation. Talk to our team about taking your international application into Belgium and the rest of Europe.

Frequently Asked Questions

Can I enter the PCT national phase in Belgium directly?

No. Belgium closed its national route for PCT applications. The European Patent Office is the only designated Office, so you reach Belgium by entering the European regional phase and then validating the granted European patent.

What is the deadline to reach Belgium from a PCT application?

You must enter the European regional phase at the EPO by 31 months from your earliest priority date. Miss it and the application lapses as to Belgium.

Do I need a translation to validate in Belgium?

No. For European patents granted on or after 1 January 2017, Belgium requires no translation at all. A patent granted in English, French or German takes effect in Belgium without any further translation.

What makes Belgian validation cheap?

Since the 2017 reform removed all translation requirements, there is no specification or claims translation to commission. The main ongoing cost is annual renewal fees to the Belgian Office for Intellectual Property.

Where are Belgian patent disputes heard?

The Brussels Enterprise Court has exclusive jurisdiction over national patent cases. Belgium also hosts a local division of the Unified Patent Court in Brussels for unitary and non-opted-out European patents.